News & Updates
Filter by Specialty:
Fluvoxamine may prevent COVID-19 hospitalization
Treatment with the selective serotonin reuptake inhibitor fluvoxamine may prevent hospitalization in outpatients presenting with symptoms of COVID-19 who have a high risk for disease progression, according to results of the TOGETHER trial.
Fluvoxamine may prevent COVID-19 hospitalization
18 Jan 2022Goji berries a potential arsenal against age-related macular degeneration
Eating a small serving of dried goji berries regularly shows promise in preventing or delaying the development of age-related macular degeneration in healthy middle-aged men and women, as reported in a study.
Goji berries a potential arsenal against age-related macular degeneration
18 Jan 2022Can atorvastatin save COVID-19 patients in intensive care?
Use of atorvastatin in adults with COVID-19 admitted to the intensive care unit (ICU) is safe but does not result in a marked decrease in the composite of venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or all-cause mortality, a study has shown.
Can atorvastatin save COVID-19 patients in intensive care?
18 Jan 2022Side effects from COVID-19 vaccines short-lived, vary according to age, sex
Vaccines against the coronavirus disease 2019 (COVID-19) often cause temporary disturbances in cardiovascular, respiratory, and sleep physiology, according to a new study. Moreover, such perturbations can be detected by wearable devices.